Oxidized LDL and fructosamine associated with severity of coronary artery atherosclerosis in insulin resistant pigs fed a high fat/high NaCl diet

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Nichols, Timothy C ^a   Merricks, Elizabeth P ^a   Bellinger, Dwight A ^a   Raymer, Robin A ^a   Yu, Jing ^b   Lam, Diana ^b   Koch, Gary G ^b   Busby, Walker H ^a   Clemmons, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; C REACTIVE PROTEIN; FRUCTOSAMINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; LOW DENSITY LIPOPROTEIN; SALT INTAKE;

ABDOMINAL AORTA; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; BLOOD PRESSURE; BODY FAT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE SEVERITY; FEMALE; HIGH SODIUM INTAKE; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; NONHUMAN; PIG; PROTEIN GLYCOSYLATION; VASCULAR REMODELING; WEIGHT GAIN; ADVERSE EFFECTS; ANIMAL; BLOOD; CORONARY ARTERY DISEASE; DISEASE MODEL; DRUG EFFECTS; PATHOPHYSIOLOGY; PHARMACOLOGY; SALT INTAKE; SEVERITY OF ILLNESS INDEX;

SUIDAE; SUS SCROFA;

ANIMALS; BLOOD PRESSURE; CORONARY ARTERY DISEASE; DISEASE MODELS, ANIMAL; FRUCTOSAMINE; INSULIN RESISTANCE; LIPOPROTEINS, LDL; SEVERITY OF ILLNESS INDEX; SODIUM CHLORIDE, DIETARY; SUS SCROFA;

EID: 84940094671     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132302     Document Type: Article

References (117)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782-7. PMID: 11742409
2. Kohen-Avramoglu R, Theriault A, Adeli K. Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidemia. Clin Biochem. 2003;36:413-20. PMID: 12951167
3. Pinhas-Hamiel O, Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet. 2007;369:1823-31. PMID: 17531891
4. Meigs JB, Larson MG, D'Agostino RB, Levy D, Clouse ME, Nathan DM, et al. Coronary artery calcification in type 2 diabetes and insulin resistance: the Framingham offspring study. Diabetes care. 2002;25:1313-9. PMID: 12145227
5. Burke AP, Kolodgie FD, Zieske A, Fowler DR, Weber DK, Varghese PJ, et al. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arteriosclerosis, thrombosis, and vascular biology. 2004;24:1266-71. PMID: 15142859
6. Graner M, Syvanne M, Kahri J, Nieminen MS, Taskinen MR. Insulin resistance as predictor of the angiographic severity and extent of coronary artery disease. Ann Med. 2007;39:137-44. PMID: 17453676
7. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arteriosclerosis, thrombosis, and vascular biology. 2000;20:1262-75. PMID: 10807742
8. Weckbach S, Findeisen HM, Schoenberg SO, Kramer H, Stark R, Clevert DA, et al. Systemic Cardiovascular Complications in Patients With Long-Standing Diabetes Mellitus: Comprehensive Assessment With Whole-Body Magnetic Resonance Imaging/Magnetic Resonance Angiography. Invest Radiol. 2009;44.
9. Flaherty JD, Davidson CJ. Diabetes and coronary revascularization. JAMA. 2005;293:1501-8. PMID: 15784875
10. Zhang H, Yuan X, Osnabrugge RL, Meng D, Gao H, Zhang S, et al. Influence of diabetes mellitus on long-term clinical and economic outcomes after coronary artery bypass grafting. Ann Thorac Surg. 2014;97:2073-9. doi: 10.1016/j.athoracsur.2014.02.047 PMID: 24751154
11. Finn AV, Palacios IF, Kastrati A, Gold HK. Drug-eluting stents for diabetes mellitus: a rush to judgment? J Am Coll Cardiol. 2005;45:479-83. PMID: 15708689
12. Yamagishi S, Nakamura K, Takeuchi M, Imaizumi T. Molecular mechanism for accelerated atherosclerosis in diabetes and its potential therapeutic intervention. Int J Clin Pharmacol Res. 2004;24:129-34. PMID: 15754918
13. Moreno PR, Fuster V. New aspects in the pathogenesis of diabetic atherothrombosis. J Am Coll Cardiol. 2004;44:2293-300. PMID: 15607389
14. Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990-2010. The New England journal of medicine. 2014;370:1514-23. doi: 10.1056/NEJMoa1310799 PMID: 24738668
15. Zoungas S, Chalmers J, Neal B, Billot L, Li Q, Hirakawa Y, et al. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. The New England journal of medicine. 2014;371:1392-406. doi: 10.1056/NEJMoa1407963 PMID: 25234206
16. Gerrity RG, Natarajan R, Nadler JL, Kimsey T. Diabetes-induced accelerated atherosclerosis in swine. Diabetes. 2001;50:1654-65. PMID: 11423488
17. Suzuki LA, Poot M, Gerrity RG, Bornfeldt KE. Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels. Diabetes. 2001;50:851-60. PMID: 11289052
18. Bellinger DA, Merricks EP, Nichols TC. Swine models of type 2 diabetes mellitus: insulin resistance, glucose tolerance, and cardiovascular complications. ILAR J. 2006;47:243-58. PMID: 16804199
19. Hasler-Rapacz JO, Nichols TC, Griggs TR, Bellinger DA, Rapacz J. Familial and diet-induced hypercholesterolemia in swine. Lipid, ApoB, and ApoA-I concentrations and distributions in plasma and lipoprotein subfractions. Arterioscler Thromb. 1994;14:923-30. PMID: 8199183
20. Hasler-Rapacz J, Ellegren H, Fridolfsson AK, Kirkpatrick B, Kirk S, Andersson L, et al. Identification of a mutation in the low density lipoprotein receptor gene associated with recessive familial hypercholesterolemia in swine. Am J Med Genet. 1998;76:379-86. PMID: 9556295
21. Grunwald KA, Schueler K, Uelmen PJ, Lipton BA, Kaiser M, Buhman K, et al. Identification of a novel Arg→Cys mutation in the LDL receptor that contributes to spontaneous hypercholesterolemia in pigs. Journal of lipid research. 1999;40:475-85. PMID: 10064736
22. Nichols TC, Du Laney T, Zheng B, Bellinger DA, Nickols GA, Engleman W, et al. Reduction in atherosclerotic lesion size in pigs by alphaVbeta3 inhibitors is associated with inhibition of insulin-like growth factor-I-mediated signaling. Circulation research. 1999;85:1040-5. PMID: 10571535
23. Brodala N, Merricks EP, Bellinger DA, Damrongsri D, Offenbacher S, Beck J, et al. Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs. Arteriosclerosis, thrombosis, and vascular biology. 2005;25:1456-1.
24. Nutrient Requirements of Swine Tenth Revised Edition ed. Subcommittee on Swine Nutrition, Committee on Animal Nutrition, Board on Agriculture, Council NR, editors: The National Academies Press; 1998.
25. Behme MT. Dietary fish oil enhances insulin sensitivity in miniature pigs. J Nutr. 1996;126:1549-53. PMID: 8648427
26. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev. 1985;6:45-86. PMID: 3884329
27. Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. The Journal of clinical investigation. 1987;79:790-800. PMID: 3546379
28. Moses AC, Young SC, Morrow LA, O'Brien M, Clemmons DR. Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes. 1996;45:91-100. PMID: 8522066
29. O'Connell T, Clemmons DR. IGF-I/IGF-binding protein-3 combination improves insulin resistance by GH-dependent and independent mechanisms. J Clin Endocrinol Metab. 2002;87:4356-60. PMID: 12213898
30. Black MH, Fingerlin TE, Allayee H, Zhang W, Xiang AH, Trigo E, et al. Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans. Diabetes. 2008;57:1048-56. PMID: 18162503
31. Sam S, Sung YA, Legro RS, Dunaif A. Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome. Metabolism. 2008;57:84-9. PMID: 18078863
32. Christoffersen B, Ribel U, Raun K, Golozoubova V, Pacini G. Evaluation of different methods for assessment of insulin sensitivity in Gottingen minipigs: introduction of a new, simpler method. Am J Physiol Regul Integr Comp Physiol. 2009;297:R1195-201. doi: 10.1152/ajpregu.90851.2008 PMID: 19710388
33. Hausman GJ, Campion DR, Thomas GB. Adipose tissue cellularity and histochemistry in fetal swine as affected by genetic selection for high or low backfat. Journal of lipid research. 1983;24:223-8. PMID: 6842080
34. Buhlinger CA, Wangsness PJ, Martin RJ, Ziegler JH. Body composition, in vitro lipid metabolism and skeletal muscle characteristics in fast-growing, lean and in slow-growing, obese pigs at equal age and weight. Growth. 1978;42:225-36. PMID: 680583
35. Etherton TD, Kris-Etherton PM. Characterization of plasma lipoproteins in swine with different propensities for obesity. Lipids. 1980;15:823-9. PMID: 7442472
36. Etherton TD. Subcutaneous adipose tissue cellularity of swine with different propensities for adipose tissue growth. Growth. 1980;44:182-91. PMID: 7429285
37. McNamara JP, Martin RJ. Muscle and adipose tissue lipoprotein lipase in fetal and neonatal swine as affected by genetic selection for high or low backfat. J Anim Sci. 1982;55:1057-61. PMID: 7174550
38. Dyson MC, Alloosh M, Vuchetich JP, Mokelke EA, Sturek M. Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet. Comp Med. 2006;56:35-45. PMID: 16521858
39. Krege JH, Hodgin JB, Hagaman JR, Smithies O. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension. 1995;25:1111-5. PMID: 7737724
40. Mesangeau D, Laude D, Elghozi JL. Early detection of cardiovascular autonomic neuropathy in diabetic pigs using blood pressure and heart rate variability. Cardiovascular research. 2000;45:889-99. PMID: 10728415
41. Springett R, Sakata Y, Delpy DT. Precise measurement of cerebral blood flow in newborn piglets from the bolus passage of indocyanine green. Phys Med Biol. 2001;46:2209-25. PMID: 11512620
42. Kalela A, Ponnio M, Koivu TA, Hoyhtya M, Huhtala H, Sillanaukee P, et al. Association of serum sialic acid and MMP-9 with lipids and inflammatory markers. Eur J Clin Invest. 2000;30:99-104. PMID: 10651833
43. Lau CL, Cantu E 3rd, Gonzalez-Stawinski GV, Holzknecht ZE, Nichols TC, Posther KE, et al. The role of antibodies and von Willebrand factor in discordant pulmonary xenotransplantation. Am J Transplant. 2003;3:1065-75. PMID: 12919085
44. Daghini E, Chade AR, Krier JD, Versari D, Lerman A, Lerman LO. Acute inhibition of the endogenous xanthine oxidase improves renal hemodynamics in hypercholesterolemic pigs. Am J Physiol Regul Integr Comp Physiol. 2006;290:R609-15. PMID: 16284087
45. Chade AR, Mushin OP, Zhu X, Rodriguez-Porcel M, Grande JP, Textor SC, et al. Pathways of renal fibrosis and modulation of matrix turnover in experimental hypercholesterolemia. Hypertension. 2005;46:772-9. PMID: 16172424
46. Chade AR, Herrmann J, Zhu X, Krier JD, Lerman A, Lerman LO. Effects of proteasome inhibition on the kidney in experimental hypercholesterolemia. J Am Soc Nephrol. 2005;16:1005-12. PMID: 15716331
47. Nichols TC, Bellinger DA, Davis KE, Koch GG, Reddick RL, Read MS, et al. Porcine von Willebrand disease and atherosclerosis. Influence of polymorphism in apolipoprotein B100 genotype. Am J Pathol. 1992;140:403-15. PMID: 1739133
48. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. The New England journal of medicine. 1987;316:1371-5. PMID: 3574413
49. Holvoet P, Theilmeier G, Shivalkar B, Flameng W, Collen D. LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs. Arteriosclerosis, thrombosis, and vascular biology. 1998;18:415-22. PMID: 9514410
50. Otis CR, Wamhoff BR, Sturek M. Hyperglycemia-induced insulin resistance in diabetic dyslipidemic Yucatan swine. Comp Med. 2003;53:53-64. PMID: 12625507
51. Laber-Laird K, Smith A, Swindle MM, Colwell J. Effects of isoflurane anesthesia on glucose tolerance and insulin secretion in Yucatan minipigs. Lab Anim Sci. 1992;42:579-81. PMID: 1479810
52. Lomax MA, Karamanlidis G, Laws J, Cremers SG, Weinberg PD, Clarke L. Pigs fed saturated fat/cholesterol have a blunted hypothalamic-pituitary-adrenal function, are insulin resistant and have decreased expression of IRS-1, PGC1alpha and PPARalpha. J Nutr Biochem. 2013;24:656-63. doi: 10.1016/j.jnutbio.2012.03.013 PMID: 22819557
53. Fink LN, Costford SR, Lee YS, Jensen TE, Bilan PJ, Oberbach A, et al. Pro-Inflammatory macrophages increase in skeletal muscle of high fat-Fed mice and correlate with metabolic risk markers in humans. Obesity. 2014;22:747-57. doi: 10.1002/oby.20615 PMID: 24030890
54. Inokuchi-Shimizu S, Park EJ, Roh YS, Yang L, Zhang B, Song J, et al. TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis. The Journal of clinical investigation. 2014.
55. Lee B, Qiao L, Lu M, Yoo HS, Cheung W, Mak R, et al. C/EBPalpha regulates macrophage activation and systemic metabolism. Am J Physiol Endocrinol Metab. 2014;306:E1144-54. doi: 10.1152/ajpendo.00002.2014 PMID: 24691027
56. Lee YS, Kim JW, Osborne O, Oh Da Y, Sasik R, Schenk S, et al. Increased Adipocyte O2 Consumption Triggers HIF-1alpha, Causing Inflammation and Insulin Resistance in Obesity. Cell. 2014;157:1339-52. doi: 10.1016/j.cell.2014.05.012 PMID: 24906151
57. Oh DY, Walenta E, Akiyama TE, Lagakos WS, Lackey D, Pessentheiner AR, et al. A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice. Nature medicine. 2014.
58. Jais A, Einwallner E, Sharif O, Gossens K, Lu TT, Soyal SM, et al. Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man. Cell. 2014;158:25-40. doi: 10.1016/j.cell.2014. 04.043 PMID: 24995976
59. Spijkerman AM, Dekker JM, Nijpels G, Adriaanse MC, Kostense PJ, Ruwaard D, et al. Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the hoorn screening study. Diabetes care. 2003;26:2604-8. PMID: 12941726
60. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16:2134-40. PMID: 15901764
61. Sosenko JM, Hu D, Welty T, Howard BV, Lee E, Robbins DC. Albuminuria in recent-onset type 2 diabetes: the Strong Heart Study. Diabetes care. 2002;25:1078-84. PMID: 12032118
62. Kohler KA, McClellan WM, Ziemer DC, Kleinbaum DG, Boring JR. Risk factors for microalbuminuria in black americans with newly diagnosed type 2 diabetes. Am J Kidney Dis. 2000;36:903-13. PMID: 11054346
63. Lucove J, Vupputuri S, Heiss G, North K, Russell M. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study. Am J Kidney Dis. 2008;51:21-8. PMID: 18155529
64. Bonnet F, Marre M, Halimi JM, Stengel B, Lange C, Laville M, et al. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study. Journal of hypertension. 2006;24:1157-63. PMID: 16685216
65. Howard BV. Insulin resistance and lipid metabolism. Am J Cardiol. 1999;84:28J-32J. PMID: 10418856
66. Taskinen MR. Insulin resistance and lipoprotein metabolism. Curr Opin Lipidol. 1995;6:153-60. PMID: 7648004
67. Selvin E, Rawlings AM, Grams M, Klein R, Sharrett AR, Steffes M, et al. Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. The lancet Diabetes & endocrinology. 2014;2:279-88.
68. Higgins PJ, Garlick RL, Bunn HF. Glycosylated hemoglobin in human and animal red cells. Role of glucose permeability. Diabetes. 1982;31:743-8. PMID: 7160543
69. Armbruster DA. Fructosamine: structure, analysis, and clinical usefulness. Clin Chem. 1987;33:2153-63. PMID: 3319287
70. Wahid ST, Sultan J, Handley G, Saeed BO, Weaver JU, Robinson AC. Serum fructosamine as a marker of 5-year risk of developing diabetes mellitus in patients exhibiting stress hyperglycaemia. Diabet Med. 2002;19:543-8. PMID: 12099956
71. Herdzik E, Safranow K, Ciechanowski K. Diagnostic value of fasting capillary glucose, fructosamine and glycosylated haemoglobin in detecting diabetes and other glucose tolerance abnormalities compared to oral glucose tolerance test. Acta Diabetol. 2002;39:15-22. PMID: 12043934
72. Thornalley PJ. Glycation, receptor-mediated cell activation and vascular complications of diabetes. Diab Vasc Dis Res. 2004;1:21-2. PMID: 16305051
73. Zhang YF, Hong J, Zhan WW, Li XY, Gu WQ, Yang YS, et al. Hyperglycaemia after glucose loading is a major predictor of preclinical atherosclerosis in nondiabetic subjects. Clin Endocrinol (Oxf). 2006;64:153-7.
74. Kilhovd BK, Juutilainen A, Lehto S, Ronnemaa T, Torjesen PA, Birkeland KI, et al. High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a population-based 18-year follow-up study. Arteriosclerosis, thrombosis, and vascular biology. 2005;25:815-20. PMID: 15692098
75. Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, et al. Plasma glycated albumin level and atherosclerosis: results from the Kyushu and Okinawa Population Study (KOPS). Int J Cardiol. 2013;167:2066-72. doi: 10.1016/j.ijcard.2012.05.045 PMID: 22658569
76. Song SO, Kim KJ, Lee BW, Kang ES, Cha BS, Lee HC. Serum glycated albumin predicts the progression of carotid arterial atherosclerosis. Atherosclerosis. 2012;225:450-5. doi: 10.1016/j. atherosclerosis.2012.09.005 PMID: 23040867
77. Pu LJ, Lu L, Shen WF, Zhang Q, Zhang RY, Zhang JS, et al. Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients. Circ J. 2007;71:1067-73. PMID: 17587712
78. Nin JW, Ferreira I, Schalkwijk CG, Prins MH, Chaturvedi N, Fuller JH, et al. Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study. Diabetologia. 2009;52:705-14. doi: 10.1007/s00125-009-1263-5 PMID: 19183936
79. Negrean M, Stirban A, Stratmann B, Gawlowski T, Horstmann T, Gotting C, et al. Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr. 2007;85:1236-43. PMID: 17490958
80. Thornalley PJ. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch Biochem Biophys. 2003;419:31-40. PMID: 14568006
81. Carson AP, Steffes MW, Carr JJ, Kim Y, Gross MD, Carnethon MR, et al. Hemoglobin A1c and the Progression of Coronary Artery Calcification Among Adults Without Diabetes. Diabetes care. 2014.
82. Gokulakrishnan K, Deepa R, Velmurugan K, Ravikumar R, Karkuzhali K, Mohan V. Oxidized low-density lipoprotein and intimal medial thickness in subjects with glucose intolerance: the Chennai Urban Rural Epidemiology Study-25. Metabolism. 2007;56:245-50. PMID: 17224340
83. Yegin A, Ozben T, Yegin H. Glycation of lipoproteins and accelerated atherosclerosis in non-insulindependent diabetes mellitus. Int J Clin Lab Res. 1995;25:157-61. PMID: 8562980
84. Nilsson J, Nordin Fredrikson G, Schiopu A, Shah PK, Jansson B, Carlsson R. Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease. Curr Pharm Des. 2007;13:1021-30. PMID: 17430165
85. Meisinger C, Baumert J, Khuseyinova N, Loewel H, Koenig W. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation. 2005;112:651-7. PMID: 16043640
86. Zhang L, Zalewski A, Liu Y, Mazurek T, Cowan S, Martin JL, et al. Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation. 2003;108:472-8. PMID: 12860917
87. Ishigaki Y, Katagiri H, Gao J, Yamada T, Imai J, Uno K, et al. Impact of plasma oxidized lowdensity lipoprotein removal on atherosclerosis. Circulation. 2008;118:75-83. doi: 10.1161/CIRCULATIONAHA.107.745174 PMID: 18559699
88. Lopes-Virella MF, Hunt KJ, Baker NL, Lachin J, Nathan DM, Virella G, et al. Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes. Diabetes. 2011;60:582-9. doi: 10.2337/db10-0915 PMID: 20980456
89. Schwenke DC, D'Agostino RB Jr., Goff DC Jr., Karter AJ, Rewers MJ, Wagenknecht LE. Differences in LDL oxidizability by glycemic status: the insulin resistance atherosclerosis study. Diabetes care. 2003;26:1449-55. PMID: 12716803
90. Hussein OA, Gefen Y, Zidan JM, Karochero EY, Luder AS, Assy NN, et al. LDL oxidation is associated with increased blood hemoglobin A1c levels in diabetic patients. Clin Chim Acta. 2007;377:114-8. PMID: 17070510
91. Veiraiah A. Hyperglycemia, lipoprotein glycation, and vascular disease. Angiology. 2005;56:431-8. PMID: 16079928
92. De Castro SH, Castro-Faria-Neto HC, Gomes MB. Association of Postprandial Hyperglycemia with in Vitro LDL Oxidation in Non-Smoking Patients with Type 1 Diabetes-a Cross-Sectional Study. Rev Diabet Stud. 2005;2:157-64. PMID: 17491690
93. Schindhelm RK, Alssema M, Scheffer PG, Diamant M, Dekker JM, Barto R, et al. Fasting and postprandial glycoxidative and lipoxidative stress are increased in women with type 2 diabetes. Diabetes care. 2007;30:1789-94. PMID: 17468356
94. Serin O, Konukoglu D, Firtina S, Mavis O. Serum oxidized low density lipoprotein, paraoxonase 1 and lipid peroxidation levels during oral glucose tolerance test. Horm Metab Res. 2007;39:207-11. PMID: 17373636
95. Okopien B, Stachura-Kulach A, Kulach A, Kowalski J, Zielinski M, Wisniewska-Wanat M, et al. The risk of atherosclerosis in patients with impaired glucose tolerance. Res Commun Mol Pathol Pharmacol. 2003;113-114:87-95. PMID: 15686110
96. Edwards IJ, Wagner JD, Litwak KN, Rudel LL, Cefalu WT. Glycation of plasma low density lipoproteins increases interaction with arterial proteoglycans. Diabetes Res Clin Pract. 1999;46:9-18. PMID: 10580610
97. Edwards IJ, Terry JG, Bell-Farrow AD, Cefalu WT. Improved glucose control decreases the interaction of plasma low-density lipoproteins with arterial proteoglycans. Metabolism. 2002;51:1223-9. PMID: 12370838
98. Inoue I, Shinoda Y, Nakano T, Sassa M, Goto S, Awata T, et al. Acarbose ameliorates atherogenecity of low-density lipoprotein in patients with impaired glucose tolerance. Metabolism. 2006;55:946-52. PMID: 16784969
99. Paniagua JA, Lopez-Miranda J, Perez-Martinez P, Marin C, Vida JM, Fuentes F, et al. Oxidized-LDL levels are changed during short-term serum glucose variations and lowered with statin treatment in early Type 2 diabetes: a study of endothelial function and microalbuminuria. Diabet Med. 2005;22:1647-56. PMID: 16401307
100. Verhamme P, Quarck R, Hao H, Knaapen M, Dymarkowski S, Bernar H, et al. Dietary cholesterol withdrawal reduces vascular inflammation and induces coronary plaque stabilization in miniature pigs. Cardiovascular research. 2002;56:135-44. PMID: 12237174
101. Knopp RH, Paramsothy P. Oxidized LDL and abdominal obesity: a key to understanding the metabolic syndrome. Am J Clin Nutr. 2006;83:1-2. PMID: 16400040
102. Shin MJ, Hyun YJ, Kim OY, Kim JY, Jang Y, Lee JH. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes (Lond). 2006;30:1529-34.
103. Ho RC, Davy K, Davy B, Melby CL. Whole-body insulin sensitivity, low-density lipoprotein (LDL) particle size, and oxidized LDL in overweight, nondiabetic men. Metabolism. 2002;51:1478-83. PMID: 12404201
104. Akanji AO, Abdella N, Mojiminiyi OA. Determinants of glycated LDL levels in nondiabetic and diabetic hyperlipidaemic patients in Kuwait. Clin Chim Acta. 2002;317:171-6. PMID: 11814472
105. Karolkiewicz J, Pilaczynska-Szczesniak L, Maciaszek J, Osinski W. Insulin resistance, oxidative stress markers and the blood antioxidant system in overweight elderly men. Aging Male. 2006;9:159-63. PMID: 17050115
106. Sies H, Stahl W, Sevanian A. Nutritional, dietary and postprandial oxidative stress. J Nutr. 2005;135:969-72. PMID: 15867266
107. Tushuizen ME, Nieuwland R, Scheffer PG, Sturk A, Heine RJ, Diamant M. Two consecutive high-fat meals affect endothelial-dependent vasodilation, oxidative stress and cellular microparticles in healthy men. J Thromb Haemost. 2006;4:1003-10. PMID: 16689751
108. Christoffersen BO, Grand N, Golozoubova V, Svendsen O, Raun K. Gender-associated differences in metabolic syndrome-related parameters in Gottingen minipigs. Comp Med. 2007;57:493-504. PMID: 17974133
109. Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nature reviews Endocrinology. 2014;10:293-302. doi: 10.1038/nrendo.2014.29 PMID: 24663222
110. Juutilainen A, Kortelainen S, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes care. 2004;27:2898-904. PMID: 15562204
111. Hanssen NM, Beulens JW, Van Dieren S, Scheijen JL, Van Der AD, Spijkerman AM, et al. Plasma advanced glycation endproducts are associated with incident cardiovascular events in individuals with type 2 diabetes: a case-cohort study with a median follow-up of 10 years (EPIC-NL). Diabetes. 2014: Available on line May 21.
112. Song YM, Song SO, You YH, Yoon KH, Kang ES, Cha BS, et al. Glycated albumin causes pancreatic beta-cells dysfunction through autophagy dysfunction. Endocrinology. 2013;154:2626-39. doi: 10. 1210/en. 2013-1031 PMID: 23698718
113. Fu R, Wu S, Wu P, Qiu J. A Study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation. Europace. 2011;13:31-6. doi: 10.1093/europace/euq346 PMID: 20852292
114. Patschan S, Chen J, Polotskaia A, Mendelev N, Cheng J, Patschan D, et al. Lipid mediators of autophagy in stress-induced premature senescence of endothelial cells. American journal of physiology. 2008;294:H1119-29. doi: 10.1152/ajpheart.00713.2007 PMID: 18203850
115. La Vange LM, Koch GG. Rank score tests. Circulation. 2006;114:2528-33. PMID: 17146004
116. Dixon JL, Stoops JD, Parker JL, Laughlin MH, Weisman GA, Sturek M. Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet. Arteriosclerosis, thrombosis, and vascular biology. 1999;19:2981-92. PMID: 10591679
117. Renard C, Van Obberghen E. Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models? Diabetes Metab. 2006;32:15-29. PMID: 16523183